Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
2(15%)
Results Posted
25%(1 trials)
Terminated
2(15%)

Phase Distribution

Ph phase_3
1
8%
Ph phase_2
2
15%
Ph not_applicable
10
77%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
2(15.4%)
Phase 3Large-scale testing
1(7.7%)
N/ANon-phased studies
10(76.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(4)
Terminated(2)
Other(4)

Detailed Status

unknown4
Completed4
Recruiting2
Terminated2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (15.4%)
Phase 31 (7.7%)
N/A10 (76.9%)

Trials by Status

recruiting215%
not_yet_recruiting18%
unknown431%
completed431%
terminated215%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13